Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 2/2021

01-06-2021 | Myasthenia Gravis | Case Report

Myasthenia Gravis Following Excision of a Large Thymoma

Authors: Gyanendra Swaroop Mittal, B. Niranjan Naik, Deepak Sundriyal

Published in: Indian Journal of Surgical Oncology | Issue 2/2021

Login to get access

Excerpt

A 63-year-old gentleman presented with a history of fever and weight loss for 6 months and nonproductive cough for 3 months. There was no history of hypertension, heart disease, TB, or asthma. On examination, he had decreased breath sound on right mid zone. His neurological and musculoskeletal examination was normal and he did not have any lymphadenopathy. An initial chest radiograph showed an anterior mediastinal mass extending to the right of the ascending aorta. A contrast computed tomographic (CT) scan showed a lobulated 15×12cm heterogeneous soft tissue mass in the anterior mediastinum. There were no areas of the chest wall or pericardial invasion or lymphadenopathy (Fig. 1). Whole-body PET-CT showed FDG avid, heterogeneously enhancing soft tissue mass lesion measuring ~10.1 × 7.1 × 11.8 cm in the anterior mediastinum, displacing and compressing anterior segment of the right upper lobe and medial segment of the right middle lobe. No other FDG avid lesion in the body was seen.
Literature
1.
go back to reference Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Following study of thymoma with special reference to their clinical stages. Cancer 48:2485–2492CrossRef Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Following study of thymoma with special reference to their clinical stages. Cancer 48:2485–2492CrossRef
2.
go back to reference Lindstrom JM (2000) Acetylcholine receptors and myasthenia. Muscle Nerve 23:453–477CrossRef Lindstrom JM (2000) Acetylcholine receptors and myasthenia. Muscle Nerve 23:453–477CrossRef
3.
go back to reference Aarli JA (1999) Late-onset myasthenia gravis: a changing scene. Arch Neurol 56:25–27CrossRef Aarli JA (1999) Late-onset myasthenia gravis: a changing scene. Arch Neurol 56:25–27CrossRef
4.
go back to reference Skeie GO, Mygland A, Aarli JA, Gilhus NE (1995) Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 20:99–104CrossRef Skeie GO, Mygland A, Aarli JA, Gilhus NE (1995) Titin antibodies in patients with late onset myasthenia gravis: clinical correlations. Autoimmunity 20:99–104CrossRef
5.
go back to reference Romi F, Skeie GO, Gilhus NE, Aarli JA (2005) Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 62:442–446CrossRef Romi F, Skeie GO, Gilhus NE, Aarli JA (2005) Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 62:442–446CrossRef
6.
go back to reference Zahid I, Sharif S, Routledge T, Scarci M (2011) Video-assisted thoracoscopic surgery or trans-sternal thymectomy in the treatment of myasthenia gravis. Interact Cardiovasc Thorac Surg 12:40–46CrossRef Zahid I, Sharif S, Routledge T, Scarci M (2011) Video-assisted thoracoscopic surgery or trans-sternal thymectomy in the treatment of myasthenia gravis. Interact Cardiovasc Thorac Surg 12:40–46CrossRef
7.
go back to reference Gajdos P, Chevret S, Toyka K (2002) Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 4:Article ID CD002275 Gajdos P, Chevret S, Toyka K (2002) Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev 4:Article ID CD002275
8.
go back to reference Venuta F, Rendina EA, Giacomo TD et al (1999) Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg 15:621–625CrossRef Venuta F, Rendina EA, Giacomo TD et al (1999) Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg 15:621–625CrossRef
9.
go back to reference Richman DP, Agius MA (2003) Treatment of autoimmune myasthenia gravis. Neurology 61:1652–1661CrossRef Richman DP, Agius MA (2003) Treatment of autoimmune myasthenia gravis. Neurology 61:1652–1661CrossRef
10.
go back to reference Romi F, Gilhus NE, Aarli JA (2005) Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurol Scand 111:134–141CrossRef Romi F, Gilhus NE, Aarli JA (2005) Myasthenia gravis: clinical, immunological, and therapeutic advances. Acta Neurol Scand 111:134–141CrossRef
11.
go back to reference Sanders DB, Evoli A (2010) Immunosuppressive therapies in myasthenia gravis. Autoimmunity 43:428–435CrossRef Sanders DB, Evoli A (2010) Immunosuppressive therapies in myasthenia gravis. Autoimmunity 43:428–435CrossRef
12.
go back to reference Konishi T, Yoshiyama Y, Takamori M, Yagi K, Mukai E, Saida T, The Japanese FK506 MG Study Group (2003) Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve 28:570–574CrossRef Konishi T, Yoshiyama Y, Takamori M, Yagi K, Mukai E, Saida T, The Japanese FK506 MG Study Group (2003) Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve 28:570–574CrossRef
13.
go back to reference Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA (2003) Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10:701–706CrossRef Romi F, Gilhus NE, Varhaug JE, Myking A, Aarli JA (2003) Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10:701–706CrossRef
Metadata
Title
Myasthenia Gravis Following Excision of a Large Thymoma
Authors
Gyanendra Swaroop Mittal
B. Niranjan Naik
Deepak Sundriyal
Publication date
01-06-2021
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2021
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-021-01326-4

Other articles of this Issue 2/2021

Indian Journal of Surgical Oncology 2/2021 Go to the issue